Evolution in Massive and Submassive Pulmonary Embolism Treatment- Session 1

Topics

- Illustrate the importance of PERT program and its implications on clinical outcomes
- Discuss the components of a system wide PERT program and how it can be functional
- Identify best patients for anticoagulation alone, pharmacomechanical lysis, endovascular embolectomy, or systemic lysis
- List steps for catheter directed pharmacomechanical lysis, including facilitated lysis
- Technical aspect of endovascular thrombectomy

Moderators:

Subhash Banerjee, MD, University of Texas Southwestern Medical Center
Mehdi Shishehbor, DO, MPH, PhD, University Hospitals of Cleveland

Faculty:

Vikas Aggarwal, MD, University of Michigan
Tarek Hammad, MD, University Hospitals
Gustavo Heresi, MD, Cleveland Clinic

This activity has been approved for AMA PRA Category 1 Credit™.

Educational Grants provided by: Boston Scientific Corporation and Inari Medical